BVF Partners L P/il is 10% at LIGAND PHARMACEUTICALS INC (LGND). They have made 42 open-market trades across 19 companies since 2007, most recently 2026-06-26.
36 open-market purchases totalling $41.7M since 2007, against 6 sales. Across 28 scored buys the stock is up 6.0% at ninety days, and 2.7 points ahead of the S&P over the same stretch.
28 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 18% | 21% | 36% |
| Avg Move | -9.8% | -0.8% | +6.0% |
| Alpha | -13.2% | -1.4% | +2.7% |
| Scored | 28 | 28 | 28 |
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 40% | 20% | 20% |
| Avg Move | +0.8% | +0.9% | +23.4% |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| KYMR | SELL | 2026-06-26 | 2026-06-26 | $106.50 | $173.7M | +11.5% | +3.3% | +8.7% |
| MLTX | SELL | 2026-03-31 | 2026-04-02 | $16.79 | $63.0M | +4.4% | +1.7% | +11.0% |
| KYMR | BUY | 2022-05-26 | 2022-05-31 | $14.34 | $8.3M | -1.5% | +30.1% | +86.7% |
| IDYA | SELL | 2021-02-02 | 2021-02-04 | $18.00 | $835K | -3.2% | +11.6% | -1.2% |
| XOMA | BUY | 2020-03-25 | 2020-03-27 | $17.20 | $284K | +1.0% | +25.8% | +24.9% |
| XOMA | BUY | 2020-03-13 | 2020-03-17 | $17.64 | $2.4M | +15.8% | +40.3% | +30.5% |
| FPRX | BUY | 2019-10-29 | 2019-10-31 | $3.88 | $114K | -3.0% | -2.2% | +30.0% |
| FPRX | BUY | 2019-10-04 | 2019-10-08 | $3.73 | $1.0M | +0.8% | -1.8% | +26.5% |
| XOMA | BUY | 2018-11-30 | 2018-12-04 | $14.91 | $280K | -2.3% | -12.0% | +4.8% |
| XOMA | BUY | 2018-11-27 | 2018-11-29 | $15.10 | $897K | -1.3% | -15.4% | +3.9% |
| INFI | BUY | 2018-06-19 | 2018-06-21 | $1.65 | $9.8M | +7.8% | +1.1% | +28.3% |
| ARQL | SELL | 2018-04-04 | 2018-04-06 | $2.90 | $13.3M | +9.1% | -12.9% | +97.6% |
| XENE | BUY | 2017-06-15 | 2017-06-19 | $3.84 | $147K | -17.1% | -10.5% | -19.7% |
| XENE | BUY | 2017-06-06 | 2017-06-08 | $3.82 | $2.2M | -1.3% | -17.5% | -27.5% |
| INFI | BUY | 2017-01-03 | 2017-01-05 | $1.34 | $6K | +18.6% | +69.0% | +93.1% |
| CTIC | BUY | 2016-01-07 | 2016-01-11 | $1.22 | $1.2M | -3.3% | -75.0% | -58.2% |
| CCXI | BUY | 2012-11-06 | 2012-11-19 | $12.00 | $480K | -48.7% | -9.1% | -9.1% |
| LGND | BUY | 2012-10-26 | 2012-11-19 | $15.19 | $252K | -9.9% | -3.4% | -3.4% |
| LGND | BUY | 2011-11-18 | 2011-11-22 | $10.65 | $5.4M | -9.9% | -3.4% | -3.4% |
| LGND | BUY | 2011-10-18 | 2011-10-20 | $13.90 | $196K | -9.9% | -3.4% | -3.4% |
| LGND | BUY | 2011-10-04 | 2011-10-06 | $12.78 | $184K | -9.9% | -3.4% | -3.4% |
| CAPS | BUY | 2011-07-28 | 2011-08-01 | $0.25 | $239K | -14.9% | +11.4% | +11.4% |
| RGEN | SELL | 2009-07-06 | 2009-07-08 | $5.52 | $2.5M | -17.5% | +0.7% | +0.7% |
| ADLR | SELL | 2009-06-19 | 2009-06-23 | $2.00 | $43K | N/A | N/A | N/A |
| NBIX | BUY | 2009-01-15 | 2009-01-20 | $3.05 | $23K | -24.3% | -5.3% | -5.3% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.
| XENE | 1,014,324 | $34.0M |
| CTIC | 3,090,744 | $28.1M |
| ARQL | 1,164,374 | $23.3M |
| MLTX | 1,039,238 | $9.9M |
| KYMR | 78,787 | $8.2M |
| PRNB | 27,265 | $2.7M |
| INFI | 7,432,656 | $332K |
| CAPS | 948,700 | $81K |
| ADLR | 6,209,051 | — |
| AVGN | 8,255,715 | — |
| NPSP | 4,631,115 | — |
| NTII | 4,938,393 | — |
| ONTY | 1,898,293 | — |
| RGDO | 1,121,221 | — |
| CRXX | 8,411,399 | — |
| Total | $1.9B |
Shares reported on the most recent Form 4, priced at the 2026-06-26 close. 7 holdings could not be priced and are excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Scored | 5 | 5 | 5 |